Wild type but not deltaF508 CFTR inhibits Na+ conductance when coexpressed in Xenopus oocytes - PubMed (original) (raw)
Comparative Study
. 1996 Feb 26;381(1-2):47-52.
doi: 10.1016/0014-5793(96)00079-8.
Affiliations
- PMID: 8641437
- DOI: 10.1016/0014-5793(96)00079-8
Free article
Comparative Study
Wild type but not deltaF508 CFTR inhibits Na+ conductance when coexpressed in Xenopus oocytes
M Mall et al. FEBS Lett. 1996.
Free article
Abstract
Airway epithelial cells bearing mutations of the cystic fibrosis (CF) transmembrane conductance regulator (CFTR) possess an increased Na+ conductance along with their well described defect of cAMP dependent Cl- conductance. Currently it is not clear, how this occurs, and whether it is due to a CFTR control of epithelial Na+ conductances which might be defective in CF patients. In the present study, we have tried to identify possible interactions between both CFTR and the epithelial Na+ conductance by overexpressing respective cRNAs in Xenopus oocytes. The expression of all three (alpha, beta, gamma) subunits of the rat epithelial Na+ channel (rENaC) and wild type (wt) CFTR resulted in the expected amiloride sensitive Na+ and IBMX (1 mmol/l) activated Cl- currents, respectively. The amiloride sensitive Na+ conductance was, however, inhibited when the wt-CFTR Cl- conductance was activated by phosphodiesterase inhibition (IBMX). In contrast, IBMX had no such effect in deltaF508 and Na+ channels coexpressing oocytes. These results suggest that wt-CFTR, but not deltaF508-CFTR, is a cAMP dependent downregulator of epithelial Na+ channels. This may explain the higher Na+ conductance observed in airway epithelial cells of CF patients.
Similar articles
- The cytosolic termini of the beta- and gamma-ENaC subunits are involved in the functional interactions between cystic fibrosis transmembrane conductance regulator and epithelial sodium channel.
Ji HL, Chalfant ML, Jovov B, Lockhart JP, Parker SB, Fuller CM, Stanton BA, Benos DJ. Ji HL, et al. J Biol Chem. 2000 Sep 8;275(36):27947-56. doi: 10.1074/jbc.M002848200. J Biol Chem. 2000. PMID: 10821834 - Inhibition of epithelial Na+ currents by intracellular domains of the cystic fibrosis transmembrane conductance regulator.
Kunzelmann K, Kiser GL, Schreiber R, Riordan JR. Kunzelmann K, et al. FEBS Lett. 1997 Jan 6;400(3):341-4. doi: 10.1016/s0014-5793(96)01414-7. FEBS Lett. 1997. PMID: 9009227 - ENaC is inhibited by an increase in the intracellular Cl(-) concentration mediated through activation of Cl(-) channels.
Kunzelmann K. Kunzelmann K. Pflugers Arch. 2003 Jan;445(4):504-12. doi: 10.1007/s00424-002-0958-y. Epub 2002 Nov 20. Pflugers Arch. 2003. PMID: 12548397 Review. - Selective activation of cystic fibrosis transmembrane conductance regulator Cl- and HCO3- conductances.
Reddy MM, Quinton PM. Reddy MM, et al. JOP. 2001 Jul;2(4 Suppl):212-8. JOP. 2001. PMID: 11875262 Review.
Cited by
- Cystic Fibrosis: A Journey through Time and Hope.
Trouvé P, Saint Pierre A, Férec C. Trouvé P, et al. Int J Mol Sci. 2024 Sep 4;25(17):9599. doi: 10.3390/ijms25179599. Int J Mol Sci. 2024. PMID: 39273547 Free PMC article. Review. - CRISPR/Cas9 bioluminescence-based assay for monitoring CFTR trafficking to the plasma membrane.
Ondra M, Lenart L, Centorame A, Dumut DC, He A, Zaidi SSZ, Hanrahan JW, De Sanctis JB, Radzioch D, Hajduch M. Ondra M, et al. Life Sci Alliance. 2023 Nov 2;7(1):e202302045. doi: 10.26508/lsa.202302045. Print 2024 Jan. Life Sci Alliance. 2023. PMID: 37918963 Free PMC article. - Personalized CFTR Modulator Therapy for G85E and N1303K Homozygous Patients with Cystic Fibrosis.
Graeber SY, Balázs A, Ziegahn N, Rubil T, Vitzthum C, Piehler L, Drescher M, Seidel K, Rohrbach A, Röhmel J, Thee S, Duerr J, Mall MA, Stahl M. Graeber SY, et al. Int J Mol Sci. 2023 Aug 2;24(15):12365. doi: 10.3390/ijms241512365. Int J Mol Sci. 2023. PMID: 37569738 Free PMC article. - Furin as a therapeutic target in cystic fibrosis airways disease.
Douglas LEJ, Reihill JA, Montgomery BM, Martin SL. Douglas LEJ, et al. Eur Respir Rev. 2023 May 3;32(168):220256. doi: 10.1183/16000617.0256-2022. Print 2023 Jun 30. Eur Respir Rev. 2023. PMID: 37137509 Free PMC article. Review. - Pathophysiology of Lung Disease and Wound Repair in Cystic Fibrosis.
Conese M, Di Gioia S. Conese M, et al. Pathophysiology. 2021 Mar 10;28(1):155-188. doi: 10.3390/pathophysiology28010011. Pathophysiology. 2021. PMID: 35366275 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources